The variables that matter
Temperature is only one part of peptide stability. Moisture can increase mobility and hydrolysis; oxygen can drive oxidation of susceptible residues; light can initiate photochemical change; pH can shift deamidation or cleavage rates; surfaces can cause adsorption; and repeated opening or transfer can introduce contamination.
Solid and solution states
A dry material and the same peptide in solution may have very different degradation profiles. Once dissolved, the solvent, pH, concentration, headspace and container become part of the system. A generic web table cannot replace supplier-specific data or an in-house stability study.
Cold storage and freeze–thaw
Lower temperature often slows chemical reactions, but labels such as “refrigerated” or “frozen” are incomplete without a range, monitoring, excursion policy and container-closure information. Aliquoting may reduce repeated cycling, but it also adds transfer and labelling steps that must be controlled.
What good stability evidence looks like
A stability claim should define the tested form, packaging, conditions, time points, analytical method and acceptance criteria. The method must be capable of separating or detecting relevant change. Appearance alone is weak evidence; HPLC, LC-MS and other assays may be needed depending on the failure mode.
Minimum records
- Material, batch, form and date received.
- Storage location, monitored range and excursions.
- Opening, preparation, aliquoting and disposal dates.
- Container type, light protection and number of freeze–thaw cycles.
- Link to the applicable method, SDS and stability evidence.
Frequently asked questions
Do all peptides have the same storage requirements?
No. Sequence, formulation, physical state, water, oxygen, light and temperature can change the dominant degradation pathways.
Does freezing guarantee stability?
No. Freezing can slow some reactions, but temperature cycling, moisture, container integrity and freeze–thaw stress still matter.
How should stability be demonstrated?
With a defined, stability-indicating analytical method, controlled conditions, time points and acceptance criteria relevant to the material and study.
Sources and further reading
- Manning MC et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010.
- ICH Q1A(R2): Stability Testing.
- HSE COSHH guidance.
External sources were checked on 19 September 2026. A citation supports the statement beside it; it does not imply that a source endorses this publication or any supplier.